Vyant Bio Inc (VYNT)

NASDAQ
0.800
-0.027(-3.25%)
After Hours
0.781
-0.019(-2.363%)
- Real-time Data
  • Volume:
    24,796
  • Day's Range:
    0.790 - 0.840
  • 52 wk Range:
    0.600 - 3.240

VYNT Overview

Prev. Close
0.827
Day's Range
0.79-0.84
Revenue
1.25M
Open
0.82
52 wk Range
0.6-3.24
EPS
-1.47
Volume
24,796
Market Cap
24.12M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
96,229
P/E Ratio
-1.55
Beta
0.336
1-Year Change
-69.6%
Shares Outstanding
29,412,798
Next Earnings Date
Aug 15, 2022
What is your sentiment on Vyant Bio?
or
Market is currently closed. Voting is open during market hours.

Vyant Bio Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Vyant Bio Inc Analysis

Vyant Bio Inc Company Profile

Vyant Bio Inc Company Profile

Employees
34

Vyant Bio, Inc. (Vyant Bio) is a biotechnology drug discovery company focused on identifying unique biological targets and novel and repurposed therapeutics. Vyant Bio is also focused on combining sophisticated data science capabilities with highly functional human cell derived disease models. Vyant Bio’s central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. The Company’s platform is designed to elucidate disease pathophysiology; formulate key therapeutic hypotheses; identify and validate drug targets, cellular assays, and biomarkers to guide candidate molecule selection, and guide clinical trial patient selection and trial design. Vyant Bio’s programs are focused on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 Deficiency Disorders (CDD) and familial Parkinsons Disease (PD).

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • What is going on with this stock it should be 2$ with this volume
    0
    • Finally rocketing
      1
      • How come is going down after merge news ?
        0
        • It's actually still up... For today and hopefully it will just keep raising...
          0
        • There was the SEC filling with 4 votes and 2 votes wereto agree:- on a reverse split (up to 1-10)- issuance of 4.5m of common sharesThese are more than certainly the reason for the lack of bigger spike today...
          0
      • Not much volume
        0
        • And some profit taken
          0
      • Flat?
        0
        • Merger has been approved
          0
          • Do your own DD, but most analysts have TP >50...
            0
            • Its bullcrap their targets
              0
            • But it doesn't hurt the stock...
              0
          • 24th March.
            0
            • why?
              0
            • Vote on merger
              0
          • everybody buying up!!!!!
            0
            • Everyone sleeping... shhhh...
              1